Chronic Lymphocytic Leukemia Treatment - NCI - National …
2024年10月15日 · Chronic lymphocytic leukemia (CLL) treatment can include observation, steroids, radiation therapy, chemotherapy, surgery, or targeted therapy. Learn more about the diagnosis, prognosis, and treatment of newly diagnosed or recurrent CLL in …
Chronic lymphocytic leukemia - Diagnosis and treatment
2024年8月23日 · Your treatment options for chronic lymphocytic leukemia depend on several factors, such as the stage of your cancer, whether you're experiencing signs and symptoms, your overall health, and your preferences. Treatment may not be needed right away
Treating Chronic Lymphocytic Leukemia - American Cancer Society
If you are facing chronic lymphocytic leukemia, we can help you learn about the treatment options and possible side effects, and point you to information and services to help you in your cancer journey.
Chronic Lymphocytic Leukemia Treatment (PDQ®) - NCI
2024年10月4日 · Chronic lymphocytic leukemia (CLL) treatment options can include observation, steroids, chemotherapy, targeted therapy, and/or stem cell transplant. Get detailed information about newly diagnosed and recurrent CLL and available treatment modalities in …
Typical Treatment of Chronic Lymphocytic Leukemia
Treatment options for chronic lymphocytic leukemia (CLL) can vary, based on things like if the leukemia is causing symptoms or other problems, if the leukemia cells have certain gene or chromosome changes, and a person's age and overall health.
Overview of the treatment of chronic lymphocytic leukemia
2023年8月21日 · The selection of initial therapy for advanced stage or symptomatic disease, the treatment of relapsed or refractory disease, and the management of complications of CLL and its treatment are discussed separately. The pathophysiology, clinical manifestations, diagnosis, staging, and prognosis of CLL are also discussed separately.
The evolving frontline management of CLL: are triplets better than ...
2024年11月25日 · Frontline therapy for chronic lymphocytic leukemia (CLL) has substantially advanced in the previous decade. While monotherapy with a Bruton's tyrosine kinase (BTK) inhibitor is an excellent option for many patients, combination therapies are of high clinical interest as they can induce deep responses and durable remissions, and in many cases allow discontinuation of therapy.
Chronic Lymphocytic Leukemia Treatment (PDQ®) - National …
2024年10月4日 · CLL is diagnosed by an absolute increase in lymphocytosis and/or bone marrow infiltration coupled with the characteristic features of morphology and immunophenotype, which confirm the characteristic clonal population.
Chronic Lymphocytic Leukemia Treatment - MD Anderson …
All CLL patients in remission are at risk of recurrence, meaning the cancer could come back and require further treatments. These treatments could include new cancer drugs or drug combinations as well as a stem cell transplant. Patients typically go through multiple courses of treatment through the span of their disease.
Chronic Lymphocytic Leukemia Therapy Guided by Measurable …
2023年12月10日 · Background: The combination of ibrutinib and venetoclax has been shown to improve outcomes in patients with chronic lymphocytic leukemia (CLL) as compared with chemoimmunotherapy. Whether ibrutinib-venetoclax and personalization of treatment duration according to measurable residual disease (MRD) is more effective than fludarabine ...